Hardware, Equipment & Parts
Compare Stocks
2 / 10Stock Comparison
BMI vs ITRI
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
BMI vs ITRI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Hardware, Equipment & Parts | Hardware, Equipment & Parts |
| Market Cap | $3.65B | $3.68B |
| Revenue (TTM) | $917M | $2.35B |
| Net Income (TTM) | $142M | $289M |
| Gross Margin | 41.7% | 38.6% |
| Operating Margin | 20.0% | 13.2% |
| Forward P/E | 27.5x | 13.8x |
| Total Debt | $0.00 | $1.29B |
| Cash & Equiv. | $226M | $1.02B |
BMI vs ITRI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Badger Meter, Inc. (BMI) | 100 | 202.2 | +102.2% |
| Itron, Inc. (ITRI) | 100 | 128.8 | +28.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BMI vs ITRI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BMI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 33 yrs, beta 0.87, yield 1.2%
- Rev growth 10.9%, EPS growth 13.2%, 3Y rev CAGR 17.5%
- 253.2% 10Y total return vs ITRI's 97.1%
ITRI is the clearest fit if your priority is value and momentum.
- Lower P/E (13.8x vs 27.5x)
- -22.2% vs BMI's -44.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.9% revenue growth vs ITRI's -3.0% | |
| Value | Lower P/E (13.8x vs 27.5x) | |
| Quality / Margins | 15.5% margin vs ITRI's 12.3% | |
| Stability / Safety | Beta 0.87 vs ITRI's 1.53 | |
| Dividends | 1.2% yield; 33-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -22.2% vs BMI's -44.1% | |
| Efficiency (ROA) | 14.5% ROA vs ITRI's 7.7%, ROIC 34.5% vs 13.1% |
BMI vs ITRI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BMI vs ITRI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BMI leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ITRI is the larger business by revenue, generating $2.3B annually — 2.6x BMI's $917M. Profitability is closely matched — net margins range from 15.5% (BMI) to 12.3% (ITRI). On growth, BMI holds the edge at +7.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $917M | $2.3B |
| EBITDAEarnings before interest/tax | $218M | $367M |
| Net IncomeAfter-tax profit | $142M | $289M |
| Free Cash FlowCash after capex | $170M | $393M |
| Gross MarginGross profit ÷ Revenue | +41.7% | +38.6% |
| Operating MarginEBIT ÷ Revenue | +20.0% | +13.2% |
| Net MarginNet income ÷ Revenue | +15.5% | +12.3% |
| FCF MarginFCF ÷ Revenue | +18.5% | +16.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.6% | -3.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.6% | -16.9% |
Valuation Metrics
ITRI leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 12.7x trailing earnings, ITRI trades at a 51% valuation discount to BMI's 25.8x P/E. On an enterprise value basis, ITRI's 10.7x EV/EBITDA is more attractive than BMI's 15.7x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.6B | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $3.9B |
| Trailing P/EPrice ÷ TTM EPS | 25.84x | 12.74x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.53x | 13.77x |
| PEG RatioP/E ÷ EPS growth rate | 1.12x | — |
| EV / EBITDAEnterprise value multiple | 15.69x | 10.70x |
| Price / SalesMarket cap ÷ Revenue | 3.98x | 1.55x |
| Price / BookPrice ÷ Book value/share | 5.13x | 2.20x |
| Price / FCFMarket cap ÷ FCF | 21.49x | 9.66x |
Profitability & Efficiency
BMI leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
BMI delivers a 19.9% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $17 for ITRI. On the Piotroski fundamental quality scale (0–9), ITRI scores 7/9 vs BMI's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +19.9% | +17.2% |
| ROA (TTM)Return on assets | +14.5% | +7.7% |
| ROICReturn on invested capital | +34.5% | +13.1% |
| ROCEReturn on capital employed | +24.1% | +11.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | — | 0.74x |
| Net DebtTotal debt minus cash | -$226M | $267M |
| Cash & Equiv.Liquid assets | $226M | $1.0B |
| Total DebtShort + long-term debt | $0 | $1.3B |
| Interest CoverageEBIT ÷ Interest expense | — | 14.38x |
Total Returns (Dividends Reinvested)
ITRI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMI five years ago would be worth $14,089 today (with dividends reinvested), compared to $9,805 for ITRI. Over the past 12 months, ITRI leads with a -22.2% total return vs BMI's -44.1%. The 3-year compound annual growth rate (CAGR) favors ITRI at 7.3% vs BMI's -2.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -29.6% | -12.2% |
| 1-Year ReturnPast 12 months | -44.1% | -22.2% |
| 3-Year ReturnCumulative with dividends | -7.4% | +23.5% |
| 5-Year ReturnCumulative with dividends | +40.9% | -2.0% |
| 10-Year ReturnCumulative with dividends | +253.2% | +97.1% |
| CAGR (3Y)Annualised 3-year return | -2.5% | +7.3% |
Risk & Volatility
Evenly matched — BMI and ITRI each lead in 1 of 2 comparable metrics.
Risk & Volatility
BMI is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than ITRI's 1.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ITRI currently trades 58.4% from its 52-week high vs BMI's 48.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | 1.53x |
| 52-Week HighHighest price in past year | $256.08 | $142.00 |
| 52-Week LowLowest price in past year | $112.09 | $78.53 |
| % of 52W HighCurrent price vs 52-week peak | +48.3% | +58.4% |
| RSI (14)Momentum oscillator 0–100 | 36.2 | 37.6 |
| Avg Volume (50D)Average daily shares traded | 558K | 905K |
Analyst Outlook
BMI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates BMI as "Hold" and ITRI as "Hold". Consensus price targets imply 65.1% upside for ITRI (target: $137) vs 39.1% for BMI (target: $172). BMI is the only dividend payer here at 1.19% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $172.14 | $137.00 |
| # AnalystsCovering analysts | 18 | 37 |
| Dividend YieldAnnual dividend ÷ price | +1.2% | — |
| Dividend StreakConsecutive years of raises | 33 | 1 |
| Dividend / ShareAnnual DPS | $1.47 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +2.7% |
BMI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ITRI leads in 2 (Valuation Metrics, Total Returns). 1 tied.
BMI vs ITRI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BMI or ITRI a better buy right now?
For growth investors, Badger Meter, Inc.
(BMI) is the stronger pick with 10. 9% revenue growth year-over-year, versus -3. 0% for Itron, Inc. (ITRI). Itron, Inc. (ITRI) offers the better valuation at 12. 7x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate Badger Meter, Inc. (BMI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BMI or ITRI?
On trailing P/E, Itron, Inc.
(ITRI) is the cheapest at 12. 7x versus Badger Meter, Inc. at 25. 8x. On forward P/E, Itron, Inc. is actually cheaper at 13. 8x.
03Which is the better long-term investment — BMI or ITRI?
Over the past 5 years, Badger Meter, Inc.
(BMI) delivered a total return of +40. 9%, compared to -2. 0% for Itron, Inc. (ITRI). Over 10 years, the gap is even starker: BMI returned +253. 2% versus ITRI's +97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BMI or ITRI?
By beta (market sensitivity over 5 years), Badger Meter, Inc.
(BMI) is the lower-risk stock at 0. 87β versus Itron, Inc. 's 1. 53β — meaning ITRI is approximately 76% more volatile than BMI relative to the S&P 500.
05Which is growing faster — BMI or ITRI?
By revenue growth (latest reported year), Badger Meter, Inc.
(BMI) is pulling ahead at 10. 9% versus -3. 0% for Itron, Inc. (ITRI). On earnings-per-share growth, the picture is similar: Itron, Inc. grew EPS 25. 7% year-over-year, compared to 13. 2% for Badger Meter, Inc.. Over a 3-year CAGR, BMI leads at 17. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BMI or ITRI?
Badger Meter, Inc.
(BMI) is the more profitable company, earning 15. 5% net margin versus 12. 7% for Itron, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BMI leads at 20. 0% versus 13. 5% for ITRI. At the gross margin level — before operating expenses — BMI leads at 41. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BMI or ITRI more undervalued right now?
On forward earnings alone, Itron, Inc.
(ITRI) trades at 13. 8x forward P/E versus 27. 5x for Badger Meter, Inc. — 13. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITRI: 65. 1% to $137. 00.
08Which pays a better dividend — BMI or ITRI?
In this comparison, BMI (1.
2% yield) pays a dividend. ITRI does not pay a meaningful dividend and should not be held primarily for income.
09Is BMI or ITRI better for a retirement portfolio?
For long-horizon retirement investors, Badger Meter, Inc.
(BMI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 2% yield, +253. 2% 10Y return). Itron, Inc. (ITRI) carries a higher beta of 1. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BMI: +253. 2%, ITRI: +97. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BMI and ITRI?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BMI is a small-cap quality compounder stock; ITRI is a small-cap deep-value stock. BMI pays a dividend while ITRI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.